Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Autor: Melanie M. Ashton, Michael Berk, Chee H. Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice N. Jacka, Susan M. Cotton, Jon-Paul Khoo, Mary Lou Chatterton, Bianca E. Kavanagh, Sarah E. Nadjidai, Samantha L. Lo Monaco, Brian H. Harvey, Jerome Sarris, Gin S. Malhi, Nathan L. Dowling, Olivia M. Dean

Publikováno v: Brazilian Journal of Psychiatry, Iss 0 (2018)

Objective: Bipolar depression is characterized by neurobiological features including perturbed oxidative biology, reduction in antioxidant levels, and a concomitant rise in oxidative stress markers. Bipolar depression manifests systemic inflammation,

Externí odkaz: https://doaj.org/article/17fa33856edb457a992bc1e543baef13

A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?

Autor: Gin S Malhi, Michael Bauer, Michael Berk, Harris A. Eyre, Aswin Ratheesh, Lakshmi N. Yatham, Allan H. Young, Roger S. McIntyre, Angela Marianne Paredes Castro, Seetal Dodd, Madhukar H. Trivedi, Siegfried Kasper, Andre F. Carvalho, Trisha Suppes, Michael E. Thase, Carlos López Jaramillo, Jon Paul Khoo, Emanuel Severus, Sidney H. Kennedy, Philip B. Mitchell, Maurizio Fava

Publikováno v: The World Journal of Biological Psychiatry. 22:483-494

Major depressive disorder is a common, recurrent, disabling and costly disorder that is often severe and/or chronic, and for which non-remission on guideline concordant first-line antidepressant treatment is the norm. A sizeable percentage of patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff8a0e5040ca6e9fab4f98ad6ba575e
https://doi.org/10.1080/15622975.2020.1851052

The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013

Autor: Louisa Degenhardt, Emily Stockings, Jon Paul Khoo, Harvey Whiteford, Alize J. Ferrari, Holly E. Erskine, Theo Vos

Publikováno v: Bipolar Disorders. 18:440-450

Objectives We present the global burden of bipolar disorder based on findings from the Global Burden of Disease Study 2013 (GBD 2013). Methods Data on the epidemiology of bipolar disorder were obtained from a systematic literature review and assemble

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f60d0287b0a1afea3e3369757578b1f
https://doi.org/10.1111/bdi.12423

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Autor: Ellie Brown, Malcolm Hopwood, Olivia M Dean, Chee H. Ng, Jon-Paul Khoo, Brian H. Harvey, Sue M. Cotton, Mary Lou Chatterton, Melanie M Ashton, Felice N. Jacka, Alyna Turner, Jerome Sarris, Bianca E Kavanagh, Samantha L. Lo Monaco, Nathan Dowling, Sarah E Nadjidai, Seetal Dodd, Gin S Malhi, Michael Berk

Publikováno v: Revista Brasileira de Psiquiatria
Brazilian Journal of Psychiatry v.41 n.3 2019
Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
Brazilian Journal of Psychiatry, Volume: 41, Issue: 3, Pages: 245-253, Published: 11 OCT 2018
Brazilian Journal of Psychiatry, Iss 0 (2018)
Brazilian Journal of Psychiatry, Issue: ahead, Published: 11 OCT 2018

Objective: Bipolar depression is characterized by neurobiological features including perturbed oxidative biology, reduction in antioxidant levels, and a concomitant rise in oxidative stress markers. Bipolar depression manifests systemic inflammation,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9f1b07c1e8f8838a521a5a52177ffa
https://pubmed.ncbi.nlm.nih.gov/30328970

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder

Autor: Sergey Mosolov, F. Picarel-Blanchot, Valérie Olivier, Livia Vavrusova, Antti Ahokas, István Bitter, Michael Bauer, Sophie Matharan, Dan J. Stein, Jon Paul Khoo, Marek Jarema, Michael Van Ameringen, Cyril Hӧschl, Christian de Bodinat

Publikováno v: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 28(8)

Treatment of severely symptomatic patients with generalized anxiety disorder (GAD) raises particular concerns for clinicians. This 12-week double-blind study evaluated the efficacy of agomelatine (25–50 mg/day) in the treatment of patients with sev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c53ffb1887872f8e49be292614a456
https://pubmed.ncbi.nlm.nih.gov/30135032